Skip to main content

Odyssey Therapeutics, Inc.

corporate_fare Company Profile

Odyssey Therapeutics, Inc.

ODTX·NASDAQ·Life Sciences·CIK 0001882782

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for autoimmune and inflammatory diseases. The company's pipeline features several drug candidates. OD-001 is an oral small molecule inhibitor of receptor-interacting protein kinase 2, currently in a Phase 2a trial for the treatment of ulcerative colitis. OD-002 is an oral small molecule SLC15A4 inhibitor, designed to block the activation of interferon regulatory factor 5 (IRF5) which mediates pathogenic inflammatory responses driven by TLR7/8/9. Another candidate, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on Treg cells. The pipeline also includes a TSLP/IL-33 bispecific antagonist, an oral small molecule interleukin-1 receptor–associated kinase 4 scaffolding inhibitor, and a small molecule inhibitor of IRF5. Odyssey Therapeutics, Inc. was incorporated in 2021 and is headquartered in Boston, Massachusetts.

Odyssey Therapeutics, Inc. (NASDAQ:ODTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for ODTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for ODTX spans 8-K, 10-Q, SCHEDULE 13D, 424B4.

Recent high-impact activity:

  • Odyssey Q3 2026: $387M Cash Through H2 2028, OD-002 IND Work Complete
  • Odyssey Posts $53.1M Q3 Loss, $387M Cash Funds Runway Into H2 2028
  • Odyssey's OD-001 Clears Phase 2a Primary Endpoint in Ulcerative Colitis
  • Odyssey's OD-001 Hits Phase 2a Endpoint in Ulcerative Colitis, 20 mg BID Dose Selected
  • Pipeline Update: OD-002 CTA Filing on Track for H2 2026, Detailed OD-001 Phase 2a Results

Short Interest & Short Volume

15.43 days to cover

FINRA reported short interest of 3,347,791 shares in ODTX as of the October 30, 2026 settlement, a 2.0% increase from the prior period — about 15.4 days to cover at its recent average daily volume. On November 20, 2026, 71.2% of ODTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,347,791 shares as of October 30, 2026
Change vs prior period▲ 2.0%
Days to cover15.43 at avg daily volume of 216,970
Daily short volume (FINRA facilities)71.2% of 230,988 shares on November 20, 2026
5-day average short volume68.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with O →
$16.96
52-week range · as of 2026-11-04 $15.1 – $29.05
Market cap
$815.23M
Volume
677.8K (2.1× avg)
3-mo avg 324.4K
Live data · 2026-11-22 03:19 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ODTX - Latest Insights

ODTX
Nov 04, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.57
Real-time Price: $16.96 info
Change: -$4.61 (-21%) info
Market Cap: $815.231M info
ODTX
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.57
Real-time Price: $16.96 info
Change: -$4.61 (-21%) info
Market Cap: $815.231M info
ODTX
Oct 20, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.10
Real-time Price: $16.96 info
Change: -$1.14 (-6%) info
Market Cap: $815.231M info
ODTX
Oct 20, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $17.80
Real-time Price: $16.96 info
Change: -$0.840 (-5%) info
Market Cap: $815.231M info
ODTX
Sep 08, 2026, 7:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.97
Real-time Price: $16.96 info
Change: -$10.01 (-37%) info
Market Cap: $815.231M info
ODTX
Aug 06, 2026, 1:30 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $21.99
Real-time Price: $16.96 info
Change: -$5.03 (-23%) info
Market Cap: $815.231M info
ODTX
Aug 05, 2026, 7:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.99
Real-time Price: $16.96 info
Change: -$5.03 (-23%) info
Market Cap: $815.231M info
ODTX
Aug 04, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.13
Real-time Price: $16.96 info
Change: -$1.17 (-6%) info
Market Cap: $815.231M info
ODTX
Aug 04, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.13
Real-time Price: $16.96 info
Change: -$1.17 (-6%) info
Market Cap: $815.231M info
ODTX
Jun 23, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.72
Real-time Price: $16.96 info
Change: -$1.76 (-9%) info
Market Cap: $815.231M info
ODTX
Jun 17, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $18.48
Real-time Price: $16.96 info
Change: -$1.52 (-8%) info
Market Cap: $815.231M info
ODTX
Jun 17, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $18.48
Real-time Price: $16.96 info
Change: -$1.52 (-8%) info
Market Cap: $815.231M info
ODTX
Jun 17, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $18.48
Real-time Price: $16.96 info
Change: -$1.52 (-8%) info
Market Cap: $815.231M info
ODTX
May 18, 2026, 6:29 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $17.39
Real-time Price: $16.96 info
Change: -$0.430 (-2%) info
Market Cap: $815.231M info
ODTX
May 18, 2026, 4:06 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $17.39
Real-time Price: $16.96 info
Change: -$0.430 (-2%) info
Market Cap: $815.231M info
ODTX
May 15, 2026, 4:08 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $17.62
Real-time Price: $16.96 info
Change: -$0.660 (-4%) info
Market Cap: $815.231M info
ODTX
May 15, 2026, 2:58 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $17.59
Real-time Price: $16.96 info
Change: -$0.630 (-4%) info
Market Cap: $815.231M info
ODTX
May 11, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.45
Real-time Price: $16.96 info
Change: -$0.490 (-3%) info
Market Cap: $815.231M info
ODTX
May 08, 2026, 4:45 PM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $16.33
Real-time Price: $16.96 info
Change: +$0.630 (+4%) info
Market Cap: $815.231M info
ODTX
May 07, 2026, 9:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: N/A
Real-time Price: $16.96 info
Change: N/A info
Market Cap: $815.231M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets